Default company panoramic image
Logo

BioCurity

A nanoparticle-based therapy that prevents healthy tissue damage due to radiation exposure for cancer patients receiving radiation therapy.

  • Stage Product In Development
  • Industry Biotechnology
  • Location New Smyrna Beach, FL, USA
  • Currency USD
  • Founded October 2010
  • Employees 2

Company Summary

BioCurity’s RadGuard™ prevents tissue damage from radiation exposure that is the norm in cancer radiation treatment and terrorist nuclear threats. RadGuard™ is unique in its ability to selectively protect healthy tissue from radiation damage while still allowing radiation treatments to attack cancerous tissue.Orlando Health has invested $100,000 and has transferred IP to BioCurity to commercialize this product.

Team

Advisors

  • Default avatar
    Foley & Lardner
    Lawyer
    Unconfirmed
    Default avatar
    Craig Clayton, CPA
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Orlando Health
    Unconfirmed